Clinical Trial Update: SU5416 and Paclitaxel in Treating Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting on the combination of SU5416 with paclitaxel in adults with advanced solid tumors. The study has completed enrollment and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• SU5416 (semaxanib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: COMPLETED